Ruxolitinib

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3584 publications

Laser-assisted drug delivery of topical ruxolitinib for treatment-refractory stable nonsegmental vitiligo: A case analyzed using noninvasive imaging modalities.

Laser-assisted drug delivery of topical ruxolitinib for treatment-refractory stable nonsegmental vitiligo: A case analyzed using noninvasive imaging modalities.

Journal: JAAD case reports

Published: January 19, 2026

Advancing Knowledge of Acute Cutaneous Graft-Versus-Host Disease Wound Care: A Case Study.

Advancing Knowledge of Acute Cutaneous Graft-Versus-Host Disease Wound Care: A Case Study.

Journal: Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society

Published: January 16, 2026

AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategy.

AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategy.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2026

Halo Seborrheic Keratosis in a Patient of Color With Vitiligo.

Halo Seborrheic Keratosis in a Patient of Color With Vitiligo.

Journal: Journal of drugs in dermatology : JDD

Published: January 06, 2026

Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia.

Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia.

Journal: Leukemia & lymphoma

Published: January 05, 2026

Innovative approaches in acute graft-versus-host disease: emerging therapeutics and novel clinical trial design.

Innovative approaches in acute graft-versus-host disease: emerging therapeutics and novel clinical trial design.

Journal: Leukemia & lymphoma

Published: January 05, 2026

Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2.

Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2.

Journal: Research square

Published: December 31, 2025

Immune Checkpoint Inhibitor-Induced Concomitant Polyradiculoneuritis and Myocarditis With Positive Anti-Titin Antibodies: A Case Report and Literature Review.

Immune Checkpoint Inhibitor-Induced Concomitant Polyradiculoneuritis and Myocarditis With Positive Anti-Titin Antibodies: A Case Report and Literature Review.

Journal: Critical care explorations

Published: December 30, 2025

VEXAS syndrome mimicking relapsing polychondritis: A case report

VEXAS syndrome mimicking relapsing polychondritis: A case report

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: December 16, 2025

Current treatments, practical management, and emerging investigational therapies for myelofibrosis.

Current treatments, practical management, and emerging investigational therapies for myelofibrosis.

Journal: Expert review of hematology

Published: December 14, 2025

Selecting optimal therapy for chronic neutrophilic leukemia: new prospects based on genetic and molecular makeup.

Selecting optimal therapy for chronic neutrophilic leukemia: new prospects based on genetic and molecular makeup.

Journal: Expert opinion on pharmacotherapy

Published: December 14, 2025

An oral lichen planus-like mouse model driven by IFN-γ signaling and cytotoxic CD8+ T cells.

An oral lichen planus-like mouse model driven by IFN-γ signaling and cytotoxic CD8+ T cells.

Journal: JCI insight

Published: December 11, 2025

Showing 1-12 of 3,584

Last Updated: 02/24/2026